Personalis (PSNL) Revenue & Revenue Breakdown
Personalis Revenue Highlights
Latest Revenue (Y)
$73.48M
Latest Revenue (Q)
$22.58M
Personalis Revenue by Period
Personalis Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $73.48M | 12.97% |
2022-12-31 | $65.05M | -23.92% |
2021-12-31 | $85.49M | 8.70% |
2020-12-31 | $78.65M | 20.61% |
2019-12-31 | $65.21M | 72.62% |
2018-12-31 | $37.77M | 302.15% |
2017-12-31 | $9.39M | - |
Personalis Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $22.58M | 15.65% |
2024-03-31 | $19.52M | -0.76% |
2023-12-31 | $19.68M | 7.83% |
2023-09-30 | $18.25M | 9.27% |
2023-06-30 | $16.70M | -11.46% |
2023-03-31 | $18.86M | 12.79% |
2022-12-31 | $16.72M | 12.55% |
2022-09-30 | $14.86M | -18.54% |
2022-06-30 | $18.24M | 19.79% |
2022-03-31 | $15.23M | -26.38% |
2021-12-31 | $20.68M | -7.09% |
2021-09-30 | $22.26M | 2.73% |
2021-06-30 | $21.67M | 3.78% |
2021-03-31 | $20.88M | 3.49% |
2020-12-31 | $20.18M | 1.82% |
2020-09-30 | $19.82M | 1.65% |
2020-06-30 | $19.50M | 1.74% |
2020-03-31 | $19.16M | 5.55% |
2019-12-31 | $18.15M | 5.84% |
2019-09-30 | $17.15M | 8.39% |
2019-06-30 | $15.82M | 12.43% |
2019-03-31 | $14.07M | 6.98% |
2018-12-31 | $13.16M | 12.90% |
2018-09-30 | $11.65M | 32.45% |
2018-06-30 | $8.80M | 111.31% |
2018-03-31 | $4.16M | - |
Personalis Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ILMN | Illumina | $4.50B | $1.08B |
CRL | Charles River Laboratories | $4.13B | $1.03B |
NTRA | Natera | $1.08B | $439.76M |
MYGN | Myriad Genetics | $678.40M | $191.90M |
GH | Guardant Health | $563.95M | $177.24M |
BNR | Burning Rock Biotech | $537.43M | $125.62M |
TWST | Twist Bioscience | $312.97M | $81.46M |
CDNA | CareDx | $280.32M | $82.88M |
CSTL | Castle Biosciences | $219.79M | $85.78M |
PSNL | Personalis | $73.48M | $22.58M |
STIM | Neuronetics | $71.35M | $16.45M |
DRIO | DarioHealth | $20.35M | $6.25M |
SERA | Sera Prognostics | $306.00K | $24.00K |